Elevated interleukin-6 levels were linked to an increased risk for obesity-related cancers among patients with newly diagnosed type 2 diabetes. Elevated interleukin-6 (IL-6) levels are associated with ...
Sonnet BioTherapeutics Holdings, Inc. announced that the United States Patent and Trademark Office has issued a Notice of Allowance for a new patent related to its modified form of Interleukin-18, ...
Trop2-targeted PET/CT with 68Ga-MY6349 for the diagnosis of primary and metastatic breast cancer and evaluation towards patient stratification in Trop2-targeted ADCs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results